| 151 |
19330494 | Saxagliptin: a new DPP-4 inhibitor for the treatment of type 2 diabetes mellitus. | 2009 Mar |
3 |
| 152 |
19444391 | Saxagliptin: a new dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes. | 2009 May |
2 |
| 153 |
19743938 | Pharmacotherapy of hyperglycemia. | 2009 Oct |
1 |
| 154 |
19780719 | Inhibitor selectivity in the clinical application of dipeptidyl peptidase-4 inhibition. | 2009 Sep 28 |
1 |
| 155 |
19791828 | Saxagliptin. | 2009 Oct 22 |
1 |
| 156 |
19929711 | Exploration of the DPP-4 inhibitors with a focus on saxagliptin. | 2009 Dec |
2 |
| 157 |
19952298 | Role of the incretin pathway in the pathogenesis of type 2 diabetes mellitus. | 2009 Dec |
1 |
| 158 |
18227430 | Involvement of DPP-IV catalytic residues in enzyme-saxagliptin complex formation. | 2008 Feb |
4 |
| 159 |
18355324 | Glucose-lowering activity of the dipeptidyl peptidase-4 inhibitor saxagliptin in drug-naive patients with type 2 diabetes. | 2008 May |
2 |
| 160 |
19051153 | Saxagliptin, a dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes. | 2008 Dec |
6 |
| 161 |
17848846 | Dipeptidyl peptidase 4 (DPP-4) inhibitors and their role in Type 2 diabetes management. | 2007 Jul-Aug |
1 |
| 162 |
16364232 | Mechanism of Gly-Pro-pNA cleavage catalyzed by dipeptidyl peptidase-IV and its inhibition by saxagliptin (BMS-477118). | 2006 Jan 1 |
2 |
| 163 |
16682937 | Therapies for the treatment of type 2 diabetes mellitus based on incretin action. | 2006 Jun |
2 |
| 164 |
16318402 | Glucagon-like peptide-1-based therapies for the treatment of type 2 diabetes mellitus. | 2005 |
1 |